[CLDX] YoY Quarter Result on 31-Dec-2016 [#Q4]

Stock
[CLDX] Celldex Therapeutics, Inc.
Announcement Date
14-Mar-2017
Financial Year
2016
Quarter
31-Dec-2016 [#Q4]
Profit Trend
QoQ- -9.15%
YoY- 1.15%
Quarter Report
CLDX's Result
CLDX's Financial Summary
View:
Show?
Quarter Result
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
Revenue 887 1,764 3,456 1,874 1,790 1,477 620 6.14%
PBT -10,447 -9,402 -22,923 -32,307 -32,684 -31,821 -22,062 -11.70%
Tax -4,448 -8,746 -19,082 -5,090 836 -229 -137 78.56%
NP -10,447 -9,402 -3,841 -32,307 -32,684 -31,821 -22,062 -11.70%
Tax Rate - - - - - - - -
Total Cost 11,334 11,166 7,297 34,181 34,474 33,298 22,682 -10.91%
Ratio Analysis
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
NP Margin -1,177.79 -532.99 -111.14 -1,723.96 -1,825.92 -2,154.43 -3,558.39 -16.82%
Per Share
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
EPS -0.64 -0.81 -0.42 -4.49 -4.97 -5.33 -3.71 -25.37%
EPS Diluted -0.64 -0.81 -0.41 -4.49 -4.97 -5.33 -3.71 -25.37%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.